Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Detailing Comprehensive Solutions to Optimize the ADC Development & Manufacturing Process

Detailing Comprehensive Solutions to Optimize the ADC Development & Manufacturing Process

10:30 am - Monday 12th October 2026

Surveying market trends across ADCs formats to examine key challenges across the development lifecycle from discovery to manufacturing
Highlighting the benefits of state of-the-art analytics and process equipment and providing an overview of Sartorius’ ADC-optimized solutions
Discussing the advantages of single-use equipment for ADC processing and introducing a new manufacturing-scale TFF system

Speakers:

Marvin Machava

Marvin Machava

Application & Testing Process Engineer

Sartorius